Sharps Technology Inc. entered into agreements with Nephron SC Inc. and its subsidiaries for a five-year exclusive pre-filled copolymer syringe manufacturing deal worth approximately $188.5 million.
AI Assistant
SHARPS TECHNOLOGY INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.